Thermogenesis (NASDAQ:KOOL) announced early Friday that the company has increased its manufacturing capacity for the cord blood stem cell disposable bags for use with the AutoXpress system.
The company can now produce as many as 2,000 disposable bag sets per week, or more than 100,000 per year.
In early February, the company released disappointing 2nd quarter numbers. Executives blamed a manufacturing capacity shortfall that caused a large backlog in orders of the disposable bags.
This latest announcement, if in fact a fix, means that Thermogenesis could see enough days of increased production and sales prior to filing the next quarterly report.
KOOL 1-yr chart